title: The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease.
abstract: OBJECTIVE
  Previous studies of the association between autoimmune Addison's disease (AAD) and a nonsynonymous single nucleotide polymorphism (SNP) in the PTPN22 gene (C1858T, pR620W; SNP ID no. rs2476601) have shown conflicting results. We aimed to examine this association using additional cohorts of AAD subjects from the UK and Poland.
  
  
  METHODS
  DNA samples were obtained from UK and Polish AAD subjects (n = 251 and 87, respectively) and ethnically matched healthy controls (n = 429 and 236, respectively). Genotyping for the C1858T PTPN22 marker was performed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) assay. Meta-analysis of the results, together with those from three other populations, was performed using RevMan v5.0 software.
  
  
  RESULTS
  In 251 UK AAD subjects the frequency of the PTPN22 1858T allele was 12.2% compared to 7.8% in healthy UK controls; P = 0.008. Similarly, in 87 Polish AAD subjects the PTPN22 1858T allele was found in 19.5% of alleles compared to 11.7% in healthy Polish subjects; P = 0.010. A meta-analysis, combining these result with published data for three other populations, involving 797 AAD subjects and 2032 controls in total, showed that the 1858T allele was associated with AAD susceptibility with a pooled odds ratio (OR) of 1.44 [95% confidence interval (CI) 1.21-1.72; P = 5.6 x 10(-5)], under a fixed-effects model.
  
  
  CONCLUSIONS
  This study confirms the association between the PTPN22 1858T allele and AAD in an expanded UK cohort and in the previously unstudied Polish population. This meta-analysis allows for the first time a reliable estimate of the strength of effect of this autoimmune disease susceptibility allele across different European Caucasian populations.
authors: Institute of Human Genetics, Newcastle University, Newcastle Upon Tyne, UK.
authors: Matthew
authors: M
authors: Roycroft
authors: Marta
authors: M
authors: Fichna
authors: David
authors: D
authors: McDonald
authors: Kate
authors: K
authors: Owen
authors: Magdalena
authors: M
authors: Zurawek
authors: Maria
authors: M
authors: Gryczyńska
authors: Danuta
authors: D
authors: Januszkiewicz-Lewandowska
authors: Piotr
authors: P
authors: Fichna
authors: Heather
authors: H
authors: Cordell
authors: Peter
authors: P
authors: Donaldson
authors: Jerzy
authors: J
authors: Nowak
authors: Simon
authors: S
authors: Pearce
mesh_terms: D000224:Addison Disease / Q000208:ethnology / Q000235:genetics*; D001327:Autoimmune Diseases / Q000208:ethnology / Q000235:genetics*; D016022:Case-Control Studies; D005787:Gene Frequency / Q000235:genetics*; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D005838:Genotype; D006801:Humans; D011044:Poland; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22 / Q000235:genetics*; D014364:Tryptophan / Q000235:genetics*; D006113:United Kingdom; D044465:White People / Q000235:genetics
chemical_list: D014364:Tryptophan; C516765:PTPN22 protein, human; D054596:Protein Tyrosine Phosphatase, Non-Receptor Type 22